Beijing Science Sun Pharmaceutical Company Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
513
- Stock Symbol
-
300485
- Investments
-
4
- Share Price
-
$2.06
- (As of Friday Closing)
Beijing Science Sun Pharmaceutical Company General Information
Description
Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.
Contact Information
Website
m.ssyy.com.cnCorporate Office
- No. 8 Xingsheng Street
- Beijing Economic-Technological Development Area
- Beijing, 100176
- China
Corporate Office
- No. 8 Xingsheng Street
- Beijing Economic-Technological Development Area
- Beijing, 100176
- China
Beijing Science Sun Pharmaceutical Company Stock Performance
As of 18-Jul-2025, Beijing Science Sun Pharmaceutical Company’s stock price is $2.06. Its current market cap is $991M with 482M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.06 | $1.91 | $0.82 - $2.26 | $991M | 482M | 36.4M | $0.05 |
Beijing Science Sun Pharmaceutical Company Financials Summary
As of 31-Mar-2025, Beijing Science Sun Pharmaceutical Company has a trailing 12-month revenue of $55.4M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 271,988 | 248,357 | 572,662 | 654,277 |
| Revenue | 55,444 | 58,043 | 67,361 | 109,072 |
| EBITDA | 26,019 | (5,299) | 24,000 | 44,803 |
| Net Income | 22,447 | (9,596) | 14,547 | 30,401 |
| Total Assets | 494,020 | 486,548 | 510,990 | 517,311 |
| Total Debt | 0 | 0 | 0 | 0 |
Beijing Science Sun Pharmaceutical Company Patents
Beijing Science Sun Pharmaceutical Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-8377883-B2 | Peptide for anti-angiogenesis and use thereof | Active | 30-Sep-2006 | ||
| US-20100111988-A1 | Small peptide for anti-angiogenesis and use thereof | Active | 30-Sep-2006 |
Beijing Science Sun Pharmaceutical Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Beijing Science Sun Pharmaceutical Company Investments (4)
Beijing Science Sun Pharmaceutical Company’s most recent deal was a Later Stage VC with Biocells (Beijing). The deal was made on 15-Sep-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biocells (Beijing) | 15-Sep-2023 | Later Stage VC | Drug Discovery | ||
| Biocells (Beijing) | 18-May-2021 | Secondary Transaction - Private | Drug Discovery | ||
| Beijing Health Guard Biotechnology | 21-Dec-2020 | Later Stage VC | Biotechnology | ||
| Luzhu Biotech | 24-Jul-2019 | Later Stage VC | Drug Discovery |
Beijing Science Sun Pharmaceutical Company ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Beijing Science Sun Pharmaceutical Company Exits (2)
Beijing Science Sun Pharmaceutical Company’s most recent exit was on 21-Dec-2020 from Beijing Health Guard Biotechnology. The exit was categorized as with 9 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Beijing Health Guard Biotechnology | 21-Dec-2020 | Completed |
|
||
| Luzhu Biotech | 24-Jul-2019 | Later Stage VC | Completed |
|
Beijing Science Sun Pharmaceutical Company Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| TianBang Pharmaceutical | Shenyang, China | 2004 |
Beijing Science Sun Pharmaceutical Company FAQs
-
When was Beijing Science Sun Pharmaceutical Company founded?
Beijing Science Sun Pharmaceutical Company was founded in 1999.
-
Where is Beijing Science Sun Pharmaceutical Company headquartered?
Beijing Science Sun Pharmaceutical Company is headquartered in Beijing, China.
-
What is the size of Beijing Science Sun Pharmaceutical Company?
Beijing Science Sun Pharmaceutical Company has 513 total employees.
-
What industry is Beijing Science Sun Pharmaceutical Company in?
Beijing Science Sun Pharmaceutical Company’s primary industry is Pharmaceuticals.
-
Is Beijing Science Sun Pharmaceutical Company a private or public company?
Beijing Science Sun Pharmaceutical Company is a Public company.
-
What is Beijing Science Sun Pharmaceutical Company’s stock symbol?
The ticker symbol for Beijing Science Sun Pharmaceutical Company is 300485.
-
What is the current stock price of Beijing Science Sun Pharmaceutical Company?
As of 18-Jul-2025 the stock price of Beijing Science Sun Pharmaceutical Company is $2.06.
-
What is the current market cap of Beijing Science Sun Pharmaceutical Company?
The current market capitalization of Beijing Science Sun Pharmaceutical Company is $991M.
-
What is Beijing Science Sun Pharmaceutical Company’s current revenue?
The trailing twelve month revenue for Beijing Science Sun Pharmaceutical Company is $55.4M.
-
What is Beijing Science Sun Pharmaceutical Company’s annual earnings per share (EPS)?
Beijing Science Sun Pharmaceutical Company’s EPS for 12 months was $0.05.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
